A study in Australia estimated that adding dTpa vaccination for pregnant women to the current pertussis immunization program for children would prevent an additional 8,800 symptomatic pertussis cases (mostly unreported) and 146 hospitalizations each year in all ages, including infants and their mothers, as well as one death every 22 months. The study found maternal pertussis vaccination to be cost-effective.
Note: The formulation used in this study is abbreviated dTpa.
Full Citation:
Saul N, Wang K, Bag S et al.. 2018. Effectiveness of maternal pertussis vaccination in preventing infection and disease in infants: the NSW Public Health Network case-control study. Vaccine. 36(14).
Title of Article: Effectiveness of maternal pertussis vaccination in preventing infection and disease in infants: the NSW Public Health Network case-control study
Author(s): Saul N, Wang K, Bag S et al.
Publication Year: 2018
Publication Name: Vaccine
Publication Volume: 36(14)
Publication Source URL: https://www.ncbi.nlm.nih.gov/pubmed/29501321
DOI (Digital Object Identifier): 10.1016/j.vaccine.2018.02.047
Topics: Health
Disease Vaccines: Pertussis
Immunization Terms: Maternal immunization
Countries: Australia
WHO Regions: Western Pacific